Navigation Links
AMD discovery: New hope for treatment of vision loss
Date:2/20/2008

This release is available in French.

Montreal, February 20, 2008 Scientists have won a major battle in the fight against age-related macular degeneration, or AMD, a blinding eye disease that affects millions of people. An international team, led by researchers at Sainte-Justine Hospital and the Universit de Montral, has identified the deficient receptor that causes the dry form of AMD.

In the February edition of the medical journal PLoS Medicine, the researchers explain how a deficiency of the CD36 receptor prevents the evacuation of oxidized lipids in the eye. Those oxidized lipids in turn accumulate and attack the layers beneath and over the retina thereby causing vision loss.

Our discovery has important implications for the development of new therapies, explains lead researcher, Dr. Sylvain Chemtob, who co-authored the paper with Universit de Montral collaborator Dr. Huy Ong, a professor at the Faculty of Pharmacy, as well as Florian Sennlaub of the Institut national de la sant et de la recherche mdicale (INSERM) in France.

Chemtob, a neonatal researcher at Sainte-Justine Hospital and a professor at the Universit de Montrals Department of Pediatrics and School of Optometry, used mice and rat models to pinpoint the scavenger receptor responsible for retinal degeneration typical of dry AMD. We found that a deficiency in CD36 receptors leads to significant and progressive age-related macular degeneration, he says. CD36 deficiency leads to central vision loss a key feature of dry AMD.

This discovery brings us one step closer to treating dry AMD, which could significantly improve the quality of life of seniors who are most affected by this eye disease, added co-author Dr. Huy Ong. Now that we have also developed the molecules that activate CD 36 receptor, we are working on the validation of the efficacy of these molecules as potential therapeutic agents for dry AMD treatment with pros
'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Page: 1 2

Related medicine news :

1. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
2. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
3. No Difference Found in Treatments for Acute Kidney Failure
4. Missing Chromosome Improves Response to Brain Tumor Treatment
5. Combo Treatment Best for Melanoma, Advanced Ovarian Cancer
6. Yes, no, maybe so: New model helps identify what works in mental health treatment
7. USAID Awards $70 Million for the Prevention and Treatment of Obstetric Fistula
8. AIDS Healthcare Foundation and NCHADS Partnership Adds 8th Cambodian AIDS Treatment Center in Kirivong
9. Many Prostate Cancers Will Not Need Treatment
10. High-End Treatment Center Moonview Sanctuary Unveils Four New Core Treatment Programs
11. Respiratory Distress Treatment Studies Conflict
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... Want to improve your ... or in your easy chair? Luckily, there are plenty of back-friendly cardio exercises that ... orthopedic spine surgeon at Atlantic Spine Center . , It’s simply untrue ...
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, ... offer behavioral health counseling for persons who are obese and those who are overweight ... clear. , That mandate will affect any commercial health plan with a program year ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of ... the NAPW VIP Woman of the Year Circle. She is recognized with this prestigious ... Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional women. , ...
(Date:7/27/2015)... ... , ... The heroin epidemic is affecting the Charlotte in North Carolina equally ... rate for heroin usage has continued to climb around the country in part because ... alternative for those with an addiction to prescription opiate medications. According to WCNC, the ...
(Date:7/27/2015)... ... 27, 2015 , ... Looking to brush up on all the things you ... New Jersey has enhanced its Dental webpage with new materials, including user-friendly, educational videos, ... “Horizon is committed to offering our 3.8 million members tools and resources to help ...
Breaking Medicine News(10 mins):Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2
... with advanced cancer, their muscles will gradually waste away for ... in the August 20 issue of Cell , a ... way to reverse that process in mice. What,s more, animals ... even as their tumors continued to grow. "This ...
... Nursing doctoral student Lisa Carter-Harris has received the Johnson ... of Colleges of Nursing Minority Nursing Faculty Scholarship for ... support to graduate nursing students from minority backgrounds who ... graduation. , The AACN will hold $1,500 to cover ...
... 19, 2010 Elsevier, the world,s leading publisher ... services, today announced an exclusive partnership with The ... a complete series of computed tomography modules through ... This partnership will provide technologists access to the ...
... from Boston University School of Medicine (BUSM) have found ... exercise in its positive effect on mood and anxiety. ... of Alternative and Complementary Medicine , is the first ... levels and decreased anxiety. The researchers set out ...
... receive a liver transplant due to alcoholic liver disease ... addiction treatment before transplantation. However, alcohol use disorders can ... alcohol use after liver transplantation is not uncommon. A ... of Transplantation reveals that those at highest risk ...
... of sex in the mainstream media has led many ... published, peer-reviewed studies have indicated that there is a ... the early onset of sexual activity among teens. However, ... these findings. Published this month in the online ...
Cached Medicine News:Health News:With muscle-building treatment, mice live longer even as tumors grow 2Health News:With muscle-building treatment, mice live longer even as tumors grow 3Health News:UofL student wins national minority nursing scholarship 2Health News:Elsevier partners with ASRT to provide multimedia educational modules through Mosby's Imaging Suite 2Health News:Study identifies factors which predict alcohol use after liver transplantation 2Health News:For teens, early sex and media exposure not linked 2
(Date:7/27/2015)... Varian Medical Systems UK Ltd announced today it ... and service two new national NHS proton therapy centers in ... proton therapy system. Earlier this year, Varian announced that ... NHS centers to be constructed in London ... book the equipment portion of the order in its fiscal ...
(Date:7/27/2015)... 27, 2015   Iagnosis , the creator ... in online dermatology solutions, announced today its 2015 ... company has contractual relationships with dermatologists in 30 ... Dermatologists and Extenders Since December 2014, ... number of providers delivering care through the platform, ...
(Date:7/27/2015)... , July 27, 2015  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, today announced ... (CTA) with Heath Canada to conduct ... d-Methadone (dextromethadone, REL-1017), its novel, N-methyl-D-aspartate (NMDA) receptor ... pain. "We are very encouraged by ...
Breaking Medicine Technology:Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 2Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 4Iagnosis Reports Significant Growth YTD 2015 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 3
... 16 Trubion Pharmaceuticals, Inc. (Nasdaq: ... data regarding its SCORPION(TM) multispecific therapeutic technology at ... of Cancer Research (AACR) in Denver, April 18-22, ... data demonstrating the selectivity and high potency of ...
... Agonist to Advance for Treatment of AllergySAN DIEGO , ... company focused on the development of novel Toll-Like Receptor ... and inflammatory diseases, announced today that it has initiated ... intranasal TLR8 agonist for the treatment of allergic rhinitis. ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
This design features a solid red iris....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
Medicine Products: